CN101468945A - Technique for synthesizing vitacampher - Google Patents
Technique for synthesizing vitacampher Download PDFInfo
- Publication number
- CN101468945A CN101468945A CNA2008100507078A CN200810050707A CN101468945A CN 101468945 A CN101468945 A CN 101468945A CN A2008100507078 A CNA2008100507078 A CN A2008100507078A CN 200810050707 A CN200810050707 A CN 200810050707A CN 101468945 A CN101468945 A CN 101468945A
- Authority
- CN
- China
- Prior art keywords
- add
- reaction
- vitacampher
- water
- oxycamphor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 26
- 230000002194 synthesizing effect Effects 0.000 title claims abstract description 6
- BZFVGPPELIFTQP-FKTZTGRPSA-N (1r,4r,7r)-4,7-dimethyl-3-oxobicyclo[2.2.1]heptane-7-carbaldehyde Chemical compound C1C[C@@H]2CC(=O)[C@@]1(C)[C@]2(C)C=O BZFVGPPELIFTQP-FKTZTGRPSA-N 0.000 title claims description 34
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 90
- 238000006243 chemical reaction Methods 0.000 claims abstract description 61
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 58
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 45
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims abstract description 44
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 43
- 239000007788 liquid Substances 0.000 claims abstract description 30
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims abstract description 29
- 238000002425 crystallisation Methods 0.000 claims abstract description 27
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229910000029 sodium carbonate Inorganic materials 0.000 claims abstract description 22
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims abstract description 21
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229910052794 bromium Inorganic materials 0.000 claims abstract description 21
- 230000008025 crystallization Effects 0.000 claims abstract description 19
- 238000000605 extraction Methods 0.000 claims abstract description 19
- 239000000047 product Substances 0.000 claims abstract description 16
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims abstract description 15
- 241000723346 Cinnamomum camphora Species 0.000 claims abstract description 15
- 229930008380 camphor Natural products 0.000 claims abstract description 15
- 229960000846 camphor Drugs 0.000 claims abstract description 15
- 239000003513 alkali Substances 0.000 claims abstract description 8
- 238000005893 bromination reaction Methods 0.000 claims abstract description 8
- 239000002904 solvent Substances 0.000 claims abstract description 8
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 7
- 238000000354 decomposition reaction Methods 0.000 claims abstract description 7
- 238000005406 washing Methods 0.000 claims abstract description 7
- 230000018044 dehydration Effects 0.000 claims abstract description 6
- 238000006297 dehydration reaction Methods 0.000 claims abstract description 6
- 238000005886 esterification reaction Methods 0.000 claims abstract description 3
- 229960001701 chloroform Drugs 0.000 claims description 37
- 239000000243 solution Substances 0.000 claims description 32
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 26
- 238000013019 agitation Methods 0.000 claims description 25
- AXMKZEOEXSKFJI-UHFFFAOYSA-N 2-hydroxy-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound C1CC2(C)C(=O)C(O)C1C2(C)C AXMKZEOEXSKFJI-UHFFFAOYSA-N 0.000 claims description 22
- 238000001816 cooling Methods 0.000 claims description 22
- 235000017550 sodium carbonate Nutrition 0.000 claims description 21
- OFAQZCPBQBALHS-UHFFFAOYSA-N 2,2-dibromo-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound C1CC2(C)C(=O)C(Br)(Br)C1C2(C)C OFAQZCPBQBALHS-UHFFFAOYSA-N 0.000 claims description 16
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 13
- 229960000583 acetic acid Drugs 0.000 claims description 13
- 239000012362 glacial acetic acid Substances 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 13
- JHWIEAWILPSRMU-UHFFFAOYSA-N 2-methyl-3-pyrimidin-4-ylpropanoic acid Chemical compound OC(=O)C(C)CC1=CC=NC=N1 JHWIEAWILPSRMU-UHFFFAOYSA-N 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 11
- 238000009835 boiling Methods 0.000 claims description 10
- 235000011194 food seasoning agent Nutrition 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000012295 chemical reaction liquid Substances 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 238000001953 recrystallisation Methods 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 8
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 7
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 7
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims description 7
- 239000001110 calcium chloride Substances 0.000 claims description 7
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 7
- 239000012043 crude product Substances 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 229930182817 methionine Natural products 0.000 claims description 7
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 claims description 7
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 238000003786 synthesis reaction Methods 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- VLOHNGJRIFIHMO-UHFFFAOYSA-N chloromethane;hydrate Chemical compound O.ClC VLOHNGJRIFIHMO-UHFFFAOYSA-N 0.000 claims description 5
- 235000019628 coolness Nutrition 0.000 claims description 5
- NWFNSTOSIVLCJA-UHFFFAOYSA-L copper;diacetate;hydrate Chemical compound O.[Cu+2].CC([O-])=O.CC([O-])=O NWFNSTOSIVLCJA-UHFFFAOYSA-L 0.000 claims description 5
- 238000007599 discharging Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 239000000376 reactant Substances 0.000 claims description 5
- 230000003068 static effect Effects 0.000 claims description 5
- 238000000967 suction filtration Methods 0.000 claims description 5
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 4
- 238000007259 addition reaction Methods 0.000 claims description 2
- 238000004140 cleaning Methods 0.000 claims description 2
- 238000004042 decolorization Methods 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 230000001590 oxidative effect Effects 0.000 claims description 2
- 238000006722 reduction reaction Methods 0.000 claims description 2
- 238000007254 oxidation reaction Methods 0.000 abstract description 7
- 238000006460 hydrolysis reaction Methods 0.000 abstract description 4
- 238000002347 injection Methods 0.000 abstract description 4
- 239000007924 injection Substances 0.000 abstract description 4
- 230000003647 oxidation Effects 0.000 abstract description 4
- 230000031709 bromination Effects 0.000 abstract description 3
- 239000007795 chemical reaction product Substances 0.000 abstract description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical class [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract description 2
- 239000000460 chlorine Substances 0.000 abstract description 2
- 229910052801 chlorine Inorganic materials 0.000 abstract description 2
- 229930008384 Oxocamphor Natural products 0.000 abstract 4
- DLKVHFJZTKTFRS-UHFFFAOYSA-N Oxocamphor Chemical compound C1CC2(C=O)C(=O)CC1C2(C)C DLKVHFJZTKTFRS-UHFFFAOYSA-N 0.000 abstract 4
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical group [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 230000032050 esterification Effects 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006386 neutralization reaction Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000011591 potassium Substances 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000008399 tap water Substances 0.000 description 3
- 235000020679 tap water Nutrition 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 208000037157 Azotemia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000019926 Keshan disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- -1 decomposes Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000018578 heart valve disease Diseases 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
Images
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100507078A CN101468945B (en) | 2008-05-14 | 2008-05-14 | Technique for synthesizing vitacampher |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100507078A CN101468945B (en) | 2008-05-14 | 2008-05-14 | Technique for synthesizing vitacampher |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101468945A true CN101468945A (en) | 2009-07-01 |
CN101468945B CN101468945B (en) | 2011-12-28 |
Family
ID=40826786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100507078A Active CN101468945B (en) | 2008-05-14 | 2008-05-14 | Technique for synthesizing vitacampher |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101468945B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2624244C1 (en) * | 2016-02-10 | 2017-07-03 | Открытое акционерное общество "Ирбитский химико-фармацевтический завод" | Method of obtaining bromcumphorus |
CN110540495A (en) * | 2018-05-28 | 2019-12-06 | 江苏柯菲平医药股份有限公司 | synthetic process of camphor oxide |
CN110538141A (en) * | 2018-05-28 | 2019-12-06 | 江苏柯菲平医药股份有限公司 | oxycocamphor injection and preparation method thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2613198C1 (en) * | 2016-02-17 | 2017-03-15 | Открытое акционерное общество "Ирбитский химико-фармацевтический завод" | Method for racemic camphor bromide preparation |
-
2008
- 2008-05-14 CN CN2008100507078A patent/CN101468945B/en active Active
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2624244C1 (en) * | 2016-02-10 | 2017-07-03 | Открытое акционерное общество "Ирбитский химико-фармацевтический завод" | Method of obtaining bromcumphorus |
CN110540495A (en) * | 2018-05-28 | 2019-12-06 | 江苏柯菲平医药股份有限公司 | synthetic process of camphor oxide |
CN110538141A (en) * | 2018-05-28 | 2019-12-06 | 江苏柯菲平医药股份有限公司 | oxycocamphor injection and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN101468945B (en) | 2011-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103435518B (en) | Preparation method of metformin hydrochloride | |
CN102516130A (en) | Preparation method of metformin hydrochloride | |
CN101468945B (en) | Technique for synthesizing vitacampher | |
CN101704765B (en) | Method for synthesizing freshener n-ethyl-p-menthane-3-carboxamide | |
CA3076282C (en) | Tricyclic oxepane derivative from limax, methods of isolation, and uses thereof | |
US20160052856A1 (en) | Beta-HYDROXY-Beta-METHYLBUTYRIC ACID PURIFICATION METHOD | |
CN106632288A (en) | Method for preparing empagliflozin | |
CN102731523B (en) | Preparation method of beta-artemether | |
CN103664923B (en) | The preparation method of Nifuratel | |
CN108484536B (en) | Synthetic method of orlistat intermediate of weight-reducing drug | |
CN107216298A (en) | A kind of preparation method of butylphenyl phthaleine | |
CN103086870A (en) | Novel process for producing trichloro-acetic chloride | |
CN104326990A (en) | Method for fluoridating and synthesizing 5-flucytosine by cytosine | |
CN104557969A (en) | Production technique of clopidogrel hydrogen sulfate | |
CN104311467B (en) | Pipe reaction continuously prepares the method and device of vildagliptin | |
CN103804267B (en) | A kind of synthesis technique of vildagliptin | |
CN104829515A (en) | Pregabalin impurity preparation method | |
CN102731436A (en) | Preparation and refining method of repaglinide | |
CN115521231B (en) | Environment-friendly clean preparation method of taurine | |
CN106883202A (en) | A kind of preparation method of L ascorbyl palmitates | |
CN101580460A (en) | Synthesis method of 3, 4-dihydroxy phenylethanol | |
CN108129525B (en) | A kind of preparation method of Etoposide intermediate | |
CN114409524A (en) | Preparation method of 2, 6-dichlorophenylacetic acid | |
CN106749098A (en) | A kind of friendly process for preparing dioxopromethazine hydrochloride as oxidant with oxygen | |
CN112110796A (en) | Resorcinol refining method and concentration distillation equipment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Du Peige Inventor after: Guan Dawei Inventor after: Sun Yufeng Inventor after: Jiang Shuang Inventor after: Li Tancheng Inventor before: Guan Dawei Inventor before: Du Peige Inventor before: Sun Yufeng Inventor before: Jiang Shuang |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: GUAN DAWEI DU PEIGE SUN YUFENG JIANG SHUANG TO: DU PEIGE GUAN DAWEI SUN YUFENG JIANG SHUANG LI TANCHENG |
|
ASS | Succession or assignment of patent right |
Owner name: BEIHUA UNIVERSITY Free format text: FORMER OWNER: CHANGCHUN DAZHENG PHARMACEUTICAL TECHNOLOGY CO., LTD. Effective date: 20131231 Owner name: CHANGCHUN DAZHENG PHARMACEUTICAL TECHNOLOGY CO., L Effective date: 20131231 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 130102 CHANGCHUN, JILIN PROVINCE TO: 132000 JILIN, JILIN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131231 Address after: 132000 No. 3999, Binjiang new road, Fengman District, Jilin, Jilin Patentee after: Beihua University Patentee after: Changchun Dazheng Pharmaceutical Technology Co., Ltd. Address before: 130102 five km, long Ha Road, Jilin Town, Changchun Economic Development Zone, Sichuan Province Patentee before: Changchun Dazheng Pharmaceutical Technology Co., Ltd. |
|
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Du Peige Inventor after: Guan Dawei Inventor after: Sun Yufeng Inventor after: Jiang Shuang Inventor after: An Liping Inventor after: Li Tancheng Inventor before: Du Peige Inventor before: Guan Dawei Inventor before: Sun Yufeng Inventor before: Jiang Shuang Inventor before: Li Tancheng |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: DU PEIGE GUAN DAWEI SUN YUFENG JIANG SHUANG LI TANCHENG TO: DU PEIGE GUAN DAWEI SUN YUFENG JIANG SHUANG AN LIPING LI TANCHENG |
|
CB03 | Change of inventor or designer information |
Inventor after: Guan Dawei Inventor after: Du Peige Inventor after: Sun Yufeng Inventor after: Jiang Shuang Inventor after: An Liping Inventor after: Li Tancheng Inventor before: Du Peige Inventor before: Guan Dawei Inventor before: Sun Yufeng Inventor before: Jiang Shuang Inventor before: An Liping Inventor before: Li Tancheng |
|
CB03 | Change of inventor or designer information | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170720 Address after: 130000, Jilin Province, Changchun City, 5 kilometers long Kazakhstan Town, 888 Da Zheng Road Patentee after: Changchun Dazheng Pharmaceutical Technology Co., Ltd. Address before: 132000 No. 3999, Binjiang new road, Fengman District, Jilin, Jilin Co-patentee before: Changchun Dazheng Pharmaceutical Technology Co., Ltd. Patentee before: Beihua University |